Rationale, aims, and objectives: Underuse of anticoagulants in atrial fibrillation is known to increase the risk of stroke and is an international problem. The National Methods: Six General Practices in 1 region, became the case study sites. Quality improvement team, doctor, and pharmacist meetings within each of the General
| INTRODUCTION
Atrial fibrillation (AF) is a chronic condition affecting around 1 million people in the UK and involves a significantly increased risk of stroke.
Atrial fibrillation-related strokes are more likely to be fatal or cause severe disability. 1 National Institute for Health Care and Excellence (NICE) guidance CG180 2 recommends Non-vitamin K antagonist Oral Anticoagulants (NOACs) as equal first-line options alongside warfarin.
These guidelines suggest that antiplatelet agents (aspirin) should not be used as monotherapy to prevent non-valvular AF-related stroke.
A report by the Association of the British Pharmaceutical Industry, Stroke in Atrial Fibrillation Initiative 3 found that despite the guidance the uptake of NOACs has been lower and slower than the NICE anticipated and its use has varied widely across Clinical Commissioning Groups. Further research has also suggested that uptake is suboptimal. 4, 5 Indeed, internationally there is reported under use of anticoagulants. [6] [7] [8] A number of initiatives have been implemented to support oral anticoagulant uptake. Holt et al 9 developed and implemented a software tool used as part of the electronic health record system to improve anti-coagulation use. Using the software improved stroke and haemorrhage rates, but no significant change in prescribing was seen. Adderley et al 10 explored whether the presence of contraindications to treatment influenced prescription. However, this had little influence on the decision to prescribe anticoagulants for the prevention of stroke in the UK.
To support the implementation of the NICE guidance, the West of The involvement of GPs in the quality improvement process is not without its challenges. The King's Fund 13 has identified several barriers to quality improvement in general practice, such as GPs perceiving the "quality agenda" as the domain of the practice manager, ambivalent attitudes to continual improvement, and a lack of a systems "mind-set" (preferring autonomy). Additionally, there has been a reluctance to engage in a collective team approach, and a lack of skills in quality improvement and change leadership. 13 Quality improvement support teams taking a more systems-based approach to planning, implementing, and measuring the impact of evidencebased care have emerged to help practices implement quality improvement programmes. Here, the quality improvement team were employed in such a role to support the initiative and were keen to understand how the process worked and how a legacy of improvement could be supported. To achieve this, the realist evaluation aimed to identify whether the quality improvement process worked, determining how and in what circumstances.
| METHODS
The evaluation employed a theory-based evaluation approach, which focused on the general practice context, the underpinning programme theory (which outlines why and how the quality improvement intervention leads to certain outcomes and the conditions in which this takes place), 14 and used mixed-methods to test the programme theory.
| Evaluation environment
The programme was implemented within 1 geographical region in the UK. In total, 51 practices were involved in the overall project (n = 61%). The evaluation team concentrated on 6 GP practices selected from the 51. The sample size was based on Evans et al's 15 experience that 6 case studies provided sufficient data to examine regularities in context, mechanism, and outcomes within a realist evaluation.
Those practices involved ranged in list size and location as shown in Table 1 .
| The programme
The programme was developed following initial pilot work in phase 1.
Clinical skills training for GPs and pharmacists was offered, along with information on AF management. Attendance at an initial training session was required prior to involvement. A welcome pack for general practices including project information and posters to advertise the programme to patients. A programme website with information about treatment options and answers to frequently Following this initial stratification, a desktop assessment was undertaken first to determine which patients were suitable for a review by the GP, either face-to-face, on the telephone, or in another way chosen by the practice. A meeting was facilitated to enable patient involvement in decision-making about ongoing prescription treatment, which was guided by tools available on the website.
| Realist evaluation
Realist evaluation 16 is a theory-driven, practice-orientated evaluation method based on case study, or close observation of a programme in "real life" operation which, in this case, was the impact of the quality improvement process on anti-coagulant prescribing by local GPs.
Realist evaluation tests a programme theory (a theoretical idea of how the programme is supposed to work) and considers what works for whom, in what circumstances, and why. 16, 17 Realist outcomes are understood through careful, systematic consideration of context, mechanism, and outcome. Context (C) refers to anything external to the programme that might be acting as a barrier or facilitator to its implementation, or its intended effects. Mechanism (M) refers to the means of achieving the desired outcome and focuses on identifying causal pathways, which are first hypothesised, then tested using qualitative methods to understand complex pathways or idiosyncrasies. Outcomes (O) are the intended and unintended consequences of a programme. 18 
| Programme theory
Hypothesizing the programme theory commenced with an initial review of the evidence supporting the intervention. Key to supporting the intervention were the following: the NICE guidance, 2 European
Society of Cardiology: Guidelines for the Management of Atrial Fibrillation 19 and the Atrial Fibrillation Association: The Safe Report. 20 These provided the evidence base for best practice in the treatment of AF, leading to preventative prescribing, increased patient care, and improved resource use.
The quality improvement project team identified 3 underlying theoretical frameworks supporting the programme theory: the model for improvement, 21 complexity and systems thinking, 22 and clinical microsystems theory. 23 The model for improvement aims to accelerate innovation adoption, working alongside existing change models, which in this case included the Plan Do Study Act (PDSA) cycle. 24 Complexity and change systems theory consider an organization as a complex system composed of many components in frequent interaction. Within this programme the GP, pharmacist, quality improvement team members and patients would each have had a perspective of the system.
Analysing these different perspectives enables understanding of the processes operating within the whole system. Clinical microsystems theory also takes a systems approach but places the patient at the centre of a small, frontline network operating as part of a larger system. In this case, the practices and pharmacists participating in the intervention are viewed as a small team within the wider National Health Service (NHS).
Drawing on best practice in the treatment of AF (including preventative prescribing, enhancing the patient experience and improving resource use), the following programme theory was devised:
General practices have adopted a system for atrial fibrillation patient pathways that accords with the NICE guidance. The mechanisms that lead to the use of the system are part of a quality improvement process which includes training, information provision, and workload resources used by GPs who reason that it will help them to meet patient, surgery or personal goals.
Supporting GP practices to identify the atrial fibrillation patient pathway as a system enables evidence-based change through that system. This leads to outcomes that include a review of oral anticoagulation prescribing, shared decision-making between GPs and patients, improved value and outcomes for patients and the systems learning legacy is retained for future quality improvement programmes.
| The programme components and anticipated CMOs
Following the literature and evidence reviews, we sought clarification of our proposed theory areas and additional context, mechanism, outcome configurations through a focus group meeting with the quality improvement team, see Table 2 .
| Data collection methods
Ethical approvals were secured from the University ethics committee.
This preceded qualitative data collection in the practices, which was completed with informed consent in place for those individuals involved.
| Observations
The evaluation team members attended the practice-based meetings between the quality improvement team and the practice lead GP and in case study site 2, the pharmacist was also present. These meetings were scheduled to occur at 3 stages: the initial planning meeting, followed by review and concluding meetings. 
| Interviews
Individual interviews were completed with GP practice leads regarding what had "worked well" in the quality improvement process, using the context, mechanism, and outcome hypothesis as a framework. The GPs were selected as they had led the implementation in the practices and had been involved with the quality improvement process. In case study site 2, the pharmacist was part of the interview process. In total, 17 interviews took place (see Table 3 ),
providing rich data about the quality improvement implementation process.
| Recruitment process and sampling strategy
The project encompassed 6 GP practices within 1 clinical commissioning group area. The initial aim was to select a range of different sized practices, including rural and urban catchment areas. However, in effect, the sample was a self-selecting convenience sample, being those practices who agreed to participate when approached by the West of England AHSN via email. Overall, 61% of practices in the region were involved (n = 51) and the evaluation proceeded with 6 of these.
| Data analysis
Realist evaluation analyses the data in the form of configuration patterns of context, mechanism, and outcome. 16 These patterns represent the causal pathways, where mechanisms and context are seen to relate to outcomes. The realist evaluation tests and refines the programme theory developed initially. To achieve this the evaluation analysed the data through identifying context, mechanism, and outcome configurations based on the initial programme theory.
Interviews were audio-recorded, and transcripts were subjected to a coding and memo-writing process, 25 along with the observational data recorded at the practice meetings. In coding, specific aspects of the context and mechanism and outcomes of the quality improvement process, as it unfolded in each practice, were identified. Initially, members of the team undertook an analysis of the transcriptions related to interviews and observation they had undertaken. These data were also coded independently by a second team member and the 2 sets of analysis were reviewed, developing 1 set of data for each practice. These were presented as the context, mechanism, and outcome configurations for the practice.
| Refining the programme theory
The initial programme theories were compared and contrasted with the findings from GP and pharmacist interviews and observations in the 6 GP practices. This comparison was used to refine the theory and new mechanisms and patterns were identified. However, 1 GP noted, "the workload that doctors and GP staff experience is rising…and it was sometimes difficult to allocate time… to focus on the project." (GP CS4)
As a consequence, mechanisms that allowed the practices to flexibly implement the programme and achieve the outcomes were adopted. These included aspects such as being able to determine when to start the programme, ways of engaging with the quality improvement team, and using online materials when needed.
The training provision was valued by all GP participants and positively noted by those pharmacists who attended. The website resources were used variably with practitioners engaging to greater or lesser extents.
The 6 GP practices reported changes in prescribing practice and data supporting this was collected by the quality improvement team as part of a wider quality improvement evaluation.
As shown in Table 4 , the initial theory model for improvement did take account of the range of practice settings all starting at different points and with different contextual issues.
| Theory area: Complexity theory
When reviewing the findings, it was clear that complexity theory does not take account of established pre-conceived ideas, held in 1 part of the system, of those in other parts. For example, 1 GP indicated that they deliberately avoided interactions with pharma, saying, "And you know we try not to see drug reps here, because it's very easy to alter your prescribing." (GP,
CS1)
The initial theory had assumed that bringing a collaboration of industry, commissioning and the NHS would achieve a change in prescribing, without fully appreciating the impact of previous learned routines and pre-conceptions. Table 5 shows the extent to which accountability to external bodies provided effective motivation for practices. This new understanding should be encompassed into the theory. Interestingly, where key motivators were in place, such as prior experience and a commitment to quality improvement and researchbased practice, the programme achieved optimal outcomes such as an efficient prescribing review, completed with patient involvement, and a lasting QI legacy (see Table 6 ). For example, the pharmacist at 1 such practice said, Practice partners encouraged to engage.
Completed the project. New protocols in place.
"they are open to best practice and change and a good clinical team here as there is no resistance to change."
There are a number of challenges to implementing NICE guidance within GP settings. 13 The West of England AHSN used a quality improvement process 12 and PDSA cycles 24 to support change implementation, uniquely bringing together key industry, commissioners, and GP stakeholders to support a review of anti-coagulation prescribing. A realist evaluation was able to show whether and how the implementation of a quality improvement process in general practices worked.
Many practices completed a review of anticoagulation prescribing, making prescription changes with patient involvement in decisionmaking seen to varying degrees. In some cases, a quality improvement legacy was also seen, with a number of GPs seeking to use the approach in the future. The evaluation was also able to provide learning about the use of a quality improvement process for the West of England AHSN, demonstrating that certain mechanisms and contexts are important in achieving desired outcomes. In particular, providing training, support, and having keen and enthusiastic local expertise involved in the delivery was critical.
In considering the findings more fully, it must be noted that there were some limitations in the evaluation. The 6 practices taking part in the study were self-selecting, agreeing to take part. This recruitment approach can preference the selection of those with a more positive stance and should be considered as potentially limiting the validity of the study. It should also be noted that significant resource was made available to the practices involved through the provision of the quality improvement team support and the additional training and website materials, which is not generally available.
It was clear that the model for improvement 12 used by the Academic Health Science Network allowed flexible implementation of the programme, which achieved some intended outcomes. In particular, the review of patient prescription was completed, and a change of prescribing practice was seen. However, the local context of the practice was an important factor in securing desired outcomes and changes in prescribing. Where GPs had personal experience or expertise in the area, this aided motivation to change and greater engagement with the project was seen. In these cases, there were reports of patient engagement in the change process and evidence of system review being implemented. However, where practices felt that their approach was already good enough, then there was limited engagement with the support in all its forms.
There was also evidence of some practices adopting the improvement process, with intention to use it as part of ongoing quality improvement activity. This was particularly the case in those practices
where GPs had more experience in AF, engaged fully with the quality improvement project, and took an active role in research.
The resources provided by the project were also valuable mechanisms in supporting the achievement of outcomes. Of particular note, the training provided by a GP, who had expertise as a cardiac specialist and passion for the subject, was highly valued. Some GPs were naturally suspicious about the future potential for working together in partnership with the pharmaceutical industry (who are viewed as profit driven). The partnership was challenging perceptions that pharma and the NHS hold opposing positions, the NHS having a business model that strives to put patients' first. 26 The clear enthusiasm and belief in the benefits of change held by the GP trainer convinced those attending that they could and should act to deliver the project. The joint steering group was also an important mechanism in challenging long-held GP views. Through this unique working relationship, it became clear that all parties were working to secure better patient outcomes and a common goal. The website materials produced were helpful to some practices. They were most often used by those GPs with less experience and interest in AF, who engaged with the range of information and support tools provided.
Some practices were already engaged with the NICE guidelines 2 and had their own systems in place for reviewing and following up patients with AF, whilst others did not. This correlates with The King's Fund finding 13 that some GPs may lack a system "mind-set" and do not have any formal system in place that will enable them to track/monitor patients. As GP practices often work in isolation, a co-ordinated project that included the provision of training, additional support from the quality improvement team and provided highly valued link pharmacists, enabled them to network with each other and share best practice. GP commitment meant they attended training, drove improvement process through, and went through website with patients.
Reviewed audit and changed patients before project start. Used website risk assessment. Legacy of annual review in development. Plan quality improvement process for other conditions.
Research-based practice focused on quality patient care. (CS2)
Research interest prompted training to be disseminated to the team, project responsibilities to be shares, and a system of pharmacy review developed.
Prevention of errors. Face-to-face consultations. Patients confident to change.
New GP, no AF nurse, or pharmacist (CS1&5). Not familiar with audit process.
GP uncertainty meant reliance on training materials and website. Additional training.
Explained risk assessments to patients. Reviewed all patients. Intend to use improvement process again. Two-way decision-making process with patients.
Spoke to other GPs. Shared review with other GPs at practice.
GP has trusting relationship with patient. (CS6)
Consultation over the phone and patient trust in their GP.
Medication changed. Workload minimized.
The provision of such support has seemingly overcome a lack of quality improvement skills and leadership that has been seen to impact on the delivery of quality improvement in general practice. 13 In conclusion, the quality improvement approach has secured the review of prescriptions and changes in patient medication, which has seen the implementation of the NICE guidelines 2 across 6 general practices. The key mechanism to adopting the NICE guidelines 2 in GP practices was their access to additional expert support and training (provided during the programme). In addition to working in close partnership with the quality improvement team, during a process of education, self-analysis/reflection on existing practice, improvement and change; this gave rise to a greater understanding of the QI process for improving the outcomes for patients with AF.
To support quality improvement, which aims to secure practice change and deliver a quality improvement legacy, the mechanisms of a team, training, and resource provision are helpful. It is also apparent that the use of a model for improvement that allows flexibility in implementation and takes account of local practice context should be encouraged.
